Gastrointestinal bleeding in hospitalized children in the United States

Chaitanya Pant1, Senthilkumar Sankararaman, Abhishek Deshpande

  • 1Department of Medicine, Kansas University Medical Center , Kansas City, KS , USA.

Insights

Gastrointestinal (GI) bleeding affects 0.5% of hospitalized children in the US, with older males and those with severe illness at higher risk. This condition significantly increases mortality risk in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Healthcare Research

Background:

  • Gastrointestinal (GI) bleeding is a significant concern in pediatric healthcare.
  • Understanding the epidemiology of GI bleeding in hospitalized children is crucial for effective management and resource allocation.

Purpose of the Study:

  • To investigate the epidemiology of GI bleeding in hospitalized children in the United States.
  • To identify demographic, clinical, and outcome-related factors associated with pediatric GI bleeding.

Main Methods:

  • Utilized the Healthcare Cost and Utilization Project Kids' Inpatient Database (2009) for national-level estimates.
  • Analyzed 23,383 pediatric discharges with GI bleeding diagnoses.
  • Compared characteristics and outcomes of children with and without GI bleeding.

Main Results:

  • GI bleeding accounted for 0.5% of pediatric hospitalizations.
  • Children with GI bleeding were more likely to be male, older (≥11 years), and have higher comorbidity and severity of illness.
  • Incidence was highest in children aged 11-15 years, with blood in stool and hematemesis being common presentations. Mortality risk was elevated, particularly in perforation cases.

Conclusions:

  • GI bleeding represents a substantial burden in hospitalized children, associated with increased mortality.
  • Findings highlight specific risk factors and presentations, informing clinical attention.
  • Study limitations include reliance on administrative codes and exclusion of non-hospitalized children.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
48
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33